Safety of the 2010–11, 2011–12, 2012–13, and 2013–14 seasonal influenza vaccines in pregnancy: Birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants, a study from the cohort arm of VAMPSS

Vaccine

Volumn 34, Issue 37, 2016, Pages 4443-4449

  Chambers, Christina D ^a,d   Johnson, Diana L ^a   Xu, Ronghui ^a   Luo, Yunjun J ^a   Louik, Carol ^b,d   Mitchell, Allen A ^b,d   Schatz, Michael ^c,d   Jones, Kenneth L ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BOSTON UNIVERSITY   (United States)

^c American Academy of Allergy   (United States)

^d Vaccines and Medications in Pregnancy Surveillance System   (United States)

Author keywords

Birth defects; Influenza vaccine; Pregnancy; Preterm delivery; Safety; Small for gestational age; Spontaneous abortion

Indexed keywords

INFLUENZA VACCINE;

ADULT; ARTICLE; BIRTH WEIGHT; BODY HEIGHT; CLINICAL EVALUATION; COHORT ANALYSIS; CONGENITAL MALFORMATION; CONTROLLED STUDY; DRUG SAFETY; FEMALE; FETUS RISK; FIRST TRIMESTER PREGNANCY; FOLLOW UP; GESTATIONAL AGE; HEAD CIRCUMFERENCE; HUMAN; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PREGNANCY; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; RISK FACTOR; SEASON; SMALL FOR DATE INFANT; SPONTANEOUS ABORTION; STILLBIRTH; ABORTION, SPONTANEOUS; CANADA; CASE CONTROL STUDY; CONGENITAL ABNORMALITIES; INFLUENZA, HUMAN; PREMATURE BIRTH; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK; UNITED STATES;

ABORTION, SPONTANEOUS; CANADA; CASE-CONTROL STUDIES; CONGENITAL ABNORMALITIES; FEMALE; HUMANS; INFANT, SMALL FOR GESTATIONAL AGE; INFLUENZA VACCINES; INFLUENZA, HUMAN; PREGNANCY; PREGNANCY OUTCOME; PREMATURE BIRTH; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK; UNITED STATES;

EID: 84979519940     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2016.06.054     Document Type: Article

References (22)

1. [1] Centers for Disease Control and Prevention, et al. Influenza vaccination coverage among pregnant women—United States, 2012–13 influenza season. MMWR Morb Mortal Wkly Rep 62 (2013), 787–792.
2. [2] Ding, H., Black, C.L., Ball, S., Donahue, S., Izrael, D., Williams, W.W., et al. Influenza vaccination coverage among pregnant women—United States, 2013–14 influenza season. MMWR Morb Mortal Wkly Rep 63 (2014), 816–821.
3. [3] Gorman, J.R., Brewer, N.T., Wang, J.B., Chambers, C.D., Theory-based predictors of influenza vaccination among pregnant women. Vaccine 17 (2012), 213–218.
4. [4] Polyzos, K., Konstantelias, A.A., Pitsa, C.E., Falagas, M.E., Maternal influenza vaccination and risk for congenital malformations: a systematic review and metal-analysis. Obstet Gynecol 126 (2015), 1075–1084.
5. [5] Chambers, C.D., Johnson, D., Xu, R., Luo, Y., Louik, C., Mitchell, A.A., Jones, K.L., OTIS Collaborative Research Group. Risks and safety of pandemic H1N1 influenza vaccine in pregnancy: birth defects, spontaneous abortiion, preterm delivery, and small for gestational age infants. Vaccine 31 (2013), 5026–5032.
6. [6] Louik, C., Ahrens, K., Kerr, S., Pyo, J., Chambers, C.D., Jones, K.L., et al. Risks and safety of pandemic H1N1 influenza vaccine in pregnancy: exposure prevalence, preterm delivery, and specific birth defects. Vaccine 31 (2013), 5033–5040.
7. [7] Nordin, J.D., Kharbanda, E.O., Benitez, G.V., Lipkind, H., Vellozzi, C., Destefano, F., Vaccine Safety Datalink. Maternal influenza vaccine and risks for preterm or small for gestational age birth. J Pediatr 164 (2014), 1051–1057.
8. [8] Ahrens, K.A., Louik, C., Kerr, S., Mitchell, A.A., Werler, M.M., Seasonal influenza vaccination during pregnancy and the risks of preterm delivery and small for gestational age birth. Paediatr Perinat Epidemiol 28 (2014), 496–509.
9. [9] Schatz, M., Chambers, C.D., Jones, K.L., Louik, C., Mitchell, A.A., Safety of influenza immunizations and treatment during pregnancy: the Vaccines and Medications in Pregnancy Surveillance System. Am J Obstet Gynecol 204 (2011), S64–S68.
10. [10] Louik C, Kerr S, Van Bennekon CM, Chambers CD, Jones KL, Schatz M, et al. Safety of the 2011–12, 2012–13, and 2013–14 seasonal influenza vaccines in pregnancy: preterm delivery and specific malformations; 2016.
11. [11] Chambers, C.D., Braddock, S.R., Briggs, G.G., Einarson, A., Johnson, Y.R., Miller, R.K., et al. Postmarketing surveillance for human teratogenicity: a model approach. Teratology 64 (2001), 252–261.
12. [12] Bakhireva, L.N., Jones, K.L., Schatz, M., Johnson, D., Chambers, C.D., Organization of Teratology Information Services Research Group. Asthma medication use in pregnancy and fetal growth. J Allergy Clin Immunol 116 (2005), 503–509.
13. [13] Kelley, K.E., Kelley, T.P., Kaufman, D.W., Mitchell, A.A., The Slone Drug Dictionary: a research driven pharmacoepidemiology tool. Pharmacoepidemiol Drug Saf 12:S1 (2003), S168–S198.
14. [14] Louik, C., Chambers, C., Jacobs, D., Rice, F., Johnson, D., Mitchell, A.A., Influenza vaccine safety in pregnancy: can we identify exposures?. Pharmacoepidemiol Drug Saf 22 (2013), 33–39.
15. [15] Correa, A., Cragan, J.D., Kucik, J.E., Alverson, C.J., Gilboa, S.M., Balakrishnan, R., et al. Reporting birth defects surveillance data 1968, 2003. Birth Defects Res A Clin Mol Teratol 79 (2007), 65–186.
16. [16] U.S. National Center for Health Statistics 2000 growth charts; November 15, 2012. Accessed at < http://www.cdc.gov/growthcharts/clinical_charts.htm>.
17. [17] Lubchenco, L.O., Hansmann, C.O., Dressler, M., Boyd, E., Intrauterine growth as estimated from liveborn birthweight data at 24 to 42 weeks of gestaton. Pediatrics 32 (1963), 793–800.
18. [18] Lubchenco, L.O., Hansmann, C., Boyd, E., Intrauterine growth in length and head circumference as estimated from live births at gestational ages from 26 to 42 weeks. Pediatrics 37 (1966), 403–407.
19. [19] Xu, R., Luo, Y., Chambers, C., Assessing the effect of vaccine on spontaneous abortion using time, dependent covariates Cox models. Pharmacoepidemiol Drug Saf 21 (2012), 844–850.
20. [20] Brookhart, M.A., Schneeweiss, S., Rothman, K.J., Glynn, R.J., Avorn, J., Sturmer, T., Variable selection for propensity score models. Am J Epidemiol 163 (2006), 1149–1156.
21. [21] Rotnitzkey, A., Li, L., Li, X., A note on overadjustment in inverse probability weighted estimation. Biometrika 97 (2010), 997–1001.
22. [22] Hollingshead A. Four factor index of social status. Unpublished working paper. Department of Sociology, Yale University, New Haven CT; 1975. Accessed at < http://yale.edu/sociology/faculty/>.